CH|EN
Vice General Manager Yongjiang Liu Awarded Capital Labor Medal and General Manager Chunli Hao Recognized as A Caring Executive
2016-05-24
Health Guard ranked among TOP 10 on the list of "2022 Future Healthcare VB100 - Top 100 Innovative Biomedicine Companies" 2022-06-22
Beijing Health Guard Approved by NMPA to Commence Clinical Trials of the Recombinant 15-Valent HPV Vaccine 2022-03-15
Beijing Health Guard Announces IND Application for the Recombinant 15-valent HPV Vaccine Accepted for Review by NMPA 2021-12-16
Beijing Health Guard Secures over CNY 1 Billion in Pre-IPO Funding 2021-08-06
Beijing Health Guard Completes Series C Financing to Support Phase III Clinical Trials and Commercial Production of Core HPV vaccines 2020-12-25
Beijing Health Guard Announces Enrollment of First Subject in Phase III Clinical Trial of the Nonavalent HPV Vaccine 2020-12-08
Beijing Health Guard Wins BDA’s 2020 High-Value Patent Innovation Award (the First Session) 2020-10-21
Beijing Health Guard Announces Enrollment of First Subject in Phase III Clinical Trials of the Trivalent HPV Vaccine 2020-10-19
Beijing Health Guard Initiates Phase I Clinical Trial of the Recombinant Nonavalent HPV Vaccine 2019-09-02
A Win-Win Collaboration to Create a Best-In-Class Solution to Protect Against HPV Infections 2019-01-17
More